Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia

HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia

US Patent 5994100 · Granted Nov 30, 1999

Estimated economic value: $27,507,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heater with USB charger2018
Quinolines and pharmaceutical compositions thereof2009
Human LXRα variants2008
Mouse aspartic secretase-2(mASP-2)2002
Mouse aspartic secretase-1 (mASP1)2002
HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory d2002
HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory d2002
HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory d2002
Mouse aspartic secretase-1 (mASP1)2001
Splicing variant of human membrane-type matrix metalloproteinease-5 (MT-MMP5-L)2001
CRFG-1b, a target and marker for chronic renal failure2001
Cytokine family member EF-72001